Treatment Strategies in Metastatic Renal Cancer: Dose Titration in Clear Cell Renal Cell Carcinoma

Eur Urol. 2022 Sep;82(3):293-294. doi: 10.1016/j.eururo.2022.04.018. Epub 2022 May 14.

Authors

Janet E Brown¹, Stefan N Symeonides²

Affiliations

¹ Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK. Electronic address: j.e.brown@sheffield.ac.uk.
² Edinburgh Cancer Centre, University of Edinburgh, Edinburgh, UK.

PMID: 35577645
DOI: 10.1016/j.eururo.2022.04.018

No abstract available

Publication types

Editorial
Comment

MeSH terms

Axitinib
Carcinoma, Renal Cell* / pathology
Humans
Kidney Neoplasms* / pathology

Substances

Axitinib